Risk factors for failure of autologous cell therapy in patients with diabetes and chronic limb – threatening ischemia. Poster
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00023001%3A_____%2F25%3A00086031" target="_blank" >RIV/00023001:_____/25:00086031 - isvavai.cz</a>
Result on the web
—
DOI - Digital Object Identifier
—
Alternative languages
Result language
angličtina
Original language name
Risk factors for failure of autologous cell therapy in patients with diabetes and chronic limb – threatening ischemia. Poster
Original language description
Autologous cell therapy (ACT) is a revascularision method for patients with no-optionchronic limb-threatening ischemia (CLTI). The aim of our study was to identify patients who benefitmost from ACT and to analyze factors responsible of failure of this therapy.
Czech name
—
Czech description
—
Classification
Type
O - Miscellaneous
CEP classification
—
OECD FORD branch
30202 - Endocrinology and metabolism (including diabetes, hormones)
Result continuities
Project
<a href="/en/project/LX22NPO5104" target="_blank" >LX22NPO5104: National Institute for Research of Metabolic and Cardiovascular Diseases</a><br>
Continuities
P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)
Others
Publication year
2025
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů